`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`
`
`
`
`
`Plaintiff
`
`SEAGEN INC.,
`
`
`
`v.
`
`
`DAIICHI SANKYO CO., LTD.
`
` Defendant
`
`ASTRAZENECA PHARMACEUTICALS
`LP, and ASTRAZENECA UK LTD.
`
` Intervenor
`
`
`
`
`
`CASE NO. 2:20-cv-00337-JRG
`
`
`
`
`
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`§
`
`REPORT OF MEDIATION
`
`The above-captioned case was mediated in person by David Folsom on Monday,
`
`February 13, 2023, between Plaintiff Seagen Inc., Defendant Daiichi Sankyo Co., Ltd., and
`
`Intervenor, Astrazeneca Pharmaceuticals LP, and Astrazeneca UK Ltd. The mediation ended at
`
`an impasse.
`
`Signed this 26th day of February 2023.
`
`
`/s/ David Folsom
`David Folsom
`TXBN: 07210800
`FOLSOM ADR PLLC
`6002-B Summerfield Drive
`Texarkana, Texas 75503
`Telephone: (903) 277-7303
`E-mail: david@folsomadr.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 492 Filed 02/26/23 Page 2 of 2 PageID #: 21424
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that the foregoing document was filed electronically in
`compliance with Local Rule CV-5(a) on this 26th day of February 2023. As such, this document
`was served on all counsel who are deemed to have consented to electronic service. Local Rule
`CV-5(a)(3)(A).
`
`/s/ David Folsom
`
` David Folsom
`
`